Teladoc Health Inc. (NYSE:TDOC) went up by 4.18% from its latest closing price compared to the recent 1-year high of $253.00. The company’s stock price has collected 14.49% of gains in the last five trading sessions. Press Release reported on 01/11/21 that Teladoc Health and Dexcom Bring CGM Technology and Personalized Insights to People with Type 2 Diabetes at No Cost
Is It Worth Investing in Teladoc Health Inc. (NYSE :TDOC) Right Now?
Plus, the 36-month beta value for TDOC is at 0.23. Opinions of the stock are interesting as 18 analysts out of 31 who provided ratings for Teladoc Health Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 11 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $245.18, which is $12.59 above the current price. TDOC currently public float of 127.79M and currently shorts hold a 12.03% ratio of that float. Today, the average trading volume of TDOC was 3.40M shares.
TDOC’s Market Performance
TDOC stocks went up by 14.49% for the week, with a monthly jump of 15.62% and a quarterly performance of 5.55%, while its annual performance rate touched 139.75%. The volatility ratio for the week stands at 6.41% while the volatility levels for the past 30 days are set at 4.59% for Teladoc Health Inc.. The simple moving average for the period of the last 20 days is 12.87% for TDOC stocks with a simple moving average of 16.88% for the last 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with BTIG Research repeating the rating for TDOC by listing it as a “Buy.” The predicted price for TDOC in the upcoming period, according to BTIG Research is $240 based on the research report published on January 07th of the current year 2021.
Evercore ISI, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $215. The rating they have provided for TDOC stocks is “In-line” according to the report published on December 22nd, 2020.
Stephens gave a rating of “Equal-Weight” to TDOC, setting the target price at $210 in the report published on December 07th of the previous year.
TDOC Trading at 16.59% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.06% of loss for the given period.
Volatility was left at 4.59%, however, over the last 30 days, the volatility rate increased by 6.41%, as shares surge +15.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.60% upper at present.
During the last 5 trading sessions, TDOC rose by +14.49%, which changed the moving average for the period of 200-days by +40.16% in comparison to the 20-day moving average, which settled at $205.39. In addition, Teladoc Health Inc. saw 15.07% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at TDOC starting from Trencher Daniel, who sale 3,000 shares at the price of $227.33 back on Jan 11. After this action, Trencher Daniel now owns 8,413 shares of Teladoc Health Inc., valued at $681,990 using the latest closing price.
Verstraete Stephany, the Chief Marketing Officer of Teladoc Health Inc., sale 3,000 shares at $204.00 during a trade that took place back on Jan 06, which means that Verstraete Stephany is holding 13,276 shares at $612,000 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -12.12 for the present operating margin
- +59.62 for the gross margin
The net margin for Teladoc Health Inc. stands at -17.87. The total capital return value is set at -4.61, while invested capital returns managed to touch -6.80. Equity return is now at value -8.00, with -4.90 for asset returns.
Based on Teladoc Health Inc. (TDOC), the company’s capital structure generated 46.40 points at debt to equity in total, while total debt to capital is 31.69. Total debt to assets is 28.13, with long-term debt to equity ratio resting at 45.90. Finally, the long-term debt to capital ratio is 31.35.
When we switch over and look at the enterprise to sales, we see a ratio of 10.79, with the company’s debt to enterprise value settled at 0.08. The receivables turnover for the company is 11.01 and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.52.